MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Pembrolizumab in Combination with Cisplatin and 5-Fluorouracil as First Line treatment in Subjects with Advanced/Metastatic Esophageal Carcinoma
3Phase III in Spain, 2Phase II, 1Phase I